nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—Irinotecan—hematologic cancer	0.276	1	CrCtD
Topotecan—TOP1—hematologic cancer	0.0951	0.712	CbGaD
Topotecan—Topoisomerase Inhibitors—Daunorubicin—hematologic cancer	0.0722	0.197	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Teniposide—hematologic cancer	0.0614	0.168	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Idarubicin—hematologic cancer	0.0548	0.149	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Irinotecan—hematologic cancer	0.0466	0.127	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Mitoxantrone—hematologic cancer	0.0466	0.127	CiPCiCtD
Topotecan—TOP1MT—Irinotecan—hematologic cancer	0.0408	0.273	CbGbCtD
Topotecan—Topoisomerase Inhibitors—Etoposide—hematologic cancer	0.0365	0.0997	CiPCiCtD
Topotecan—ABCG2—hematologic cancer	0.0272	0.204	CbGaD
Topotecan—Topoisomerase Inhibitors—Epirubicin—hematologic cancer	0.0251	0.0686	CiPCiCtD
Topotecan—TOP1—Irinotecan—hematologic cancer	0.0235	0.157	CbGbCtD
Topotecan—Topoisomerase Inhibitors—Doxorubicin—hematologic cancer	0.0233	0.0635	CiPCiCtD
Topotecan—ABCB1—hematologic cancer	0.0113	0.0848	CbGaD
Topotecan—ABCG2—Clofarabine—hematologic cancer	0.00793	0.0529	CbGbCtD
Topotecan—ABCG2—Daunorubicin—hematologic cancer	0.00465	0.031	CbGbCtD
Topotecan—ABCG2—Teniposide—hematologic cancer	0.00404	0.027	CbGbCtD
Topotecan—ABCG2—Cladribine—hematologic cancer	0.00387	0.0258	CbGbCtD
Topotecan—ABCG2—Imatinib—hematologic cancer	0.00356	0.0238	CbGbCtD
Topotecan—ABCG2—Nilotinib—hematologic cancer	0.00324	0.0216	CbGbCtD
Topotecan—ABCG2—Dasatinib—hematologic cancer	0.00286	0.0191	CbGbCtD
Topotecan—ABCB1—Lenalidomide—hematologic cancer	0.00286	0.0191	CbGbCtD
Topotecan—ABCG2—Mitoxantrone—hematologic cancer	0.00283	0.0189	CbGbCtD
Topotecan—ABCG2—Irinotecan—hematologic cancer	0.00223	0.0148	CbGbCtD
Topotecan—ABCG2—Vincristine—hematologic cancer	0.00194	0.013	CbGbCtD
Topotecan—ABCG2—Cisplatin—hematologic cancer	0.00181	0.0121	CbGbCtD
Topotecan—ABCG2—Etoposide—hematologic cancer	0.00178	0.0119	CbGbCtD
Topotecan—CYP3A4—Bexarotene—hematologic cancer	0.00171	0.0114	CbGbCtD
Topotecan—ABCB1—Daunorubicin—hematologic cancer	0.00168	0.0112	CbGbCtD
Topotecan—ABCB1—Alitretinoin—hematologic cancer	0.00164	0.011	CbGbCtD
Topotecan—CYP3A4—Busulfan—hematologic cancer	0.00159	0.0106	CbGbCtD
Topotecan—CYP3A4—Lomustine—hematologic cancer	0.00159	0.0106	CbGbCtD
Topotecan—ABCG2—Dexamethasone—hematologic cancer	0.00147	0.00978	CbGbCtD
Topotecan—CYP3A4—Thiotepa—hematologic cancer	0.00142	0.00948	CbGbCtD
Topotecan—ABCB1—Imatinib—hematologic cancer	0.00128	0.00857	CbGbCtD
Topotecan—ABCG2—Doxorubicin—hematologic cancer	0.00122	0.00811	CbGbCtD
Topotecan—ABCG2—Methotrexate—hematologic cancer	0.00118	0.00786	CbGbCtD
Topotecan—ABCB1—Nilotinib—hematologic cancer	0.00117	0.00779	CbGbCtD
Topotecan—ABCB1—Vinorelbine—hematologic cancer	0.00116	0.00772	CbGbCtD
Topotecan—CYP3A4—Methoxsalen—hematologic cancer	0.0011	0.00737	CbGbCtD
Topotecan—CYP3A4—Bortezomib—hematologic cancer	0.00105	0.00701	CbGbCtD
Topotecan—ABCB1—Dasatinib—hematologic cancer	0.00103	0.00688	CbGbCtD
Topotecan—ABCB1—Mitoxantrone—hematologic cancer	0.00102	0.0068	CbGbCtD
Topotecan—CYP3A4—Daunorubicin—hematologic cancer	0.001	0.0067	CbGbCtD
Topotecan—ABCB1—Betamethasone—hematologic cancer	0.000908	0.00606	CbGbCtD
Topotecan—ABCB1—Gemcitabine—hematologic cancer	0.0009	0.00601	CbGbCtD
Topotecan—ABCB1—Prednisolone—hematologic cancer	0.000896	0.00598	CbGbCtD
Topotecan—CYP3A4—Cytarabine—hematologic cancer	0.000886	0.00591	CbGbCtD
Topotecan—CYP3A4—Teniposide—hematologic cancer	0.000873	0.00582	CbGbCtD
Topotecan—TOP1MT—gonad—hematologic cancer	0.000867	0.154	CbGeAlD
Topotecan—ABCB1—Prednisone—hematologic cancer	0.000846	0.00565	CbGbCtD
Topotecan—CYP3A4—Ifosfamide—hematologic cancer	0.000806	0.00538	CbGbCtD
Topotecan—ABCB1—Irinotecan—hematologic cancer	0.000802	0.00535	CbGbCtD
Topotecan—CYP3A4—Imatinib—hematologic cancer	0.00077	0.00514	CbGbCtD
Topotecan—CYP3A4—Ruxolitinib—hematologic cancer	0.000725	0.00484	CbGbCtD
Topotecan—ABCB1—Vinblastine—hematologic cancer	0.000713	0.00476	CbGbCtD
Topotecan—ABCB1—Vincristine—hematologic cancer	0.000701	0.00468	CbGbCtD
Topotecan—CYP3A4—Nilotinib—hematologic cancer	0.000699	0.00467	CbGbCtD
Topotecan—CYP3A4—Vinorelbine—hematologic cancer	0.000693	0.00463	CbGbCtD
Topotecan—TOP1MT—lung—hematologic cancer	0.000662	0.117	CbGeAlD
Topotecan—ABCB1—Cisplatin—hematologic cancer	0.000654	0.00436	CbGbCtD
Topotecan—ABCB1—Etoposide—hematologic cancer	0.000643	0.00429	CbGbCtD
Topotecan—CYP3A4—Triamcinolone—hematologic cancer	0.000634	0.00423	CbGbCtD
Topotecan—TOP1MT—testis—hematologic cancer	0.000625	0.111	CbGeAlD
Topotecan—CYP3A4—Dasatinib—hematologic cancer	0.000618	0.00412	CbGbCtD
Topotecan—CYP3A4—Mitoxantrone—hematologic cancer	0.000611	0.00407	CbGbCtD
Topotecan—Irinotecan—TOP1—hematologic cancer	0.000559	0.49	CrCbGaD
Topotecan—CYP3A4—Betamethasone—hematologic cancer	0.000544	0.00363	CbGbCtD
Topotecan—CYP3A4—Prednisolone—hematologic cancer	0.000537	0.00358	CbGbCtD
Topotecan—ABCB1—Dexamethasone—hematologic cancer	0.000528	0.00353	CbGbCtD
Topotecan—CYP3A4—Prednisone—hematologic cancer	0.000507	0.00338	CbGbCtD
Topotecan—CYP3A4—Irinotecan—hematologic cancer	0.000481	0.00321	CbGbCtD
Topotecan—TOP1MT—lymph node—hematologic cancer	0.000453	0.0803	CbGeAlD
Topotecan—ABCB1—Doxorubicin—hematologic cancer	0.000438	0.00292	CbGbCtD
Topotecan—CYP3A4—Vinblastine—hematologic cancer	0.000427	0.00285	CbGbCtD
Topotecan—ABCB1—Methotrexate—hematologic cancer	0.000425	0.00283	CbGbCtD
Topotecan—CYP3A4—Vincristine—hematologic cancer	0.00042	0.0028	CbGbCtD
Topotecan—TOP1—blood—hematologic cancer	0.000399	0.0706	CbGeAlD
Topotecan—TOP1—bone marrow—hematologic cancer	0.000386	0.0683	CbGeAlD
Topotecan—CYP3A4—Etoposide—hematologic cancer	0.000385	0.00257	CbGbCtD
Topotecan—TOP1—lung—hematologic cancer	0.000349	0.0619	CbGeAlD
Topotecan—TOP1—testis—hematologic cancer	0.00033	0.0584	CbGeAlD
Topotecan—CYP3A4—Dexamethasone—hematologic cancer	0.000317	0.00211	CbGbCtD
Topotecan—Irinotecan—UGT1A1—hematologic cancer	0.000285	0.25	CrCbGaD
Topotecan—CYP3A4—Doxorubicin—hematologic cancer	0.000263	0.00175	CbGbCtD
Topotecan—TOP1—lymph node—hematologic cancer	0.000239	0.0423	CbGeAlD
Topotecan—Irinotecan—ABCG2—hematologic cancer	0.00016	0.14	CrCbGaD
Topotecan—CYP3A4—hematopoietic system—hematologic cancer	0.000149	0.0263	CbGeAlD
Topotecan—ABCG2—blood—hematologic cancer	0.000141	0.0251	CbGeAlD
Topotecan—ABCG2—bone marrow—hematologic cancer	0.000137	0.0242	CbGeAlD
Topotecan—ABCG2—lung—hematologic cancer	0.000124	0.022	CbGeAlD
Topotecan—ABCG2—testis—hematologic cancer	0.000117	0.0207	CbGeAlD
Topotecan—ABCB1—hematopoietic system—hematologic cancer	0.000105	0.0186	CbGeAlD
Topotecan—CYP3A4—blood—hematologic cancer	9.85e-05	0.0175	CbGeAlD
Topotecan—ABCG2—lymph node—hematologic cancer	8.48e-05	0.015	CbGeAlD
Topotecan—ABCB1—gonad—hematologic cancer	8e-05	0.0142	CbGeAlD
Topotecan—Irinotecan—ALB—hematologic cancer	6.98e-05	0.0612	CrCbGaD
Topotecan—ABCB1—blood—hematologic cancer	6.97e-05	0.0124	CbGeAlD
Topotecan—ABCB1—bone marrow—hematologic cancer	6.75e-05	0.012	CbGeAlD
Topotecan—Irinotecan—ABCB1—hematologic cancer	6.66e-05	0.0584	CrCbGaD
Topotecan—ABCB1—lung—hematologic cancer	6.11e-05	0.0108	CbGeAlD
Topotecan—ABCB1—testis—hematologic cancer	5.77e-05	0.0102	CbGeAlD
Topotecan—ABCB1—lymph node—hematologic cancer	4.18e-05	0.00741	CbGeAlD
Topotecan—ABCG2—Transmembrane transport of small molecules—NUP214—hematologic cancer	6.18e-06	0.000427	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	6.12e-06	0.000424	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	6.06e-06	0.000419	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IFNG—hematologic cancer	5.95e-06	0.000412	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	5.94e-06	0.000411	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	5.91e-06	0.000409	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	5.86e-06	0.000405	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CDA—hematologic cancer	5.8e-06	0.000402	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	5.71e-06	0.000395	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	5.62e-06	0.000389	CbGpPWpGaD
Topotecan—Paraesthesia—Dexamethasone—hematologic cancer	5.61e-06	0.000106	CcSEcCtD
Topotecan—Discomfort—Prednisone—hematologic cancer	5.61e-06	0.000106	CcSEcCtD
Topotecan—Rash—Gemcitabine—hematologic cancer	5.61e-06	0.000106	CcSEcCtD
Topotecan—Dermatitis—Gemcitabine—hematologic cancer	5.6e-06	0.000106	CcSEcCtD
Topotecan—Hypersensitivity—Etoposide—hematologic cancer	5.6e-06	0.000106	CcSEcCtD
Topotecan—ABCG2—Metabolism—PC—hematologic cancer	5.59e-06	0.000387	CbGpPWpGaD
Topotecan—Malnutrition—Methotrexate—hematologic cancer	5.57e-06	0.000105	CcSEcCtD
Topotecan—Haemoglobin—Doxorubicin—hematologic cancer	5.57e-06	0.000105	CcSEcCtD
Topotecan—Headache—Gemcitabine—hematologic cancer	5.57e-06	0.000105	CcSEcCtD
Topotecan—Nausea—Vincristine—hematologic cancer	5.57e-06	0.000105	CcSEcCtD
Topotecan—Rhinitis—Doxorubicin—hematologic cancer	5.56e-06	0.000105	CcSEcCtD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	5.55e-06	0.000384	CbGpPWpGaD
Topotecan—Haemorrhage—Doxorubicin—hematologic cancer	5.54e-06	0.000105	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	5.53e-06	0.000382	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—MTR—hematologic cancer	5.52e-06	0.000382	CbGpPWpGaD
Topotecan—Hypersensitivity—Prednisolone—hematologic cancer	5.52e-06	0.000104	CcSEcCtD
Topotecan—Hypoaesthesia—Doxorubicin—hematologic cancer	5.52e-06	0.000104	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	5.51e-06	0.000381	CbGpPWpGaD
Topotecan—Pharyngitis—Doxorubicin—hematologic cancer	5.5e-06	0.000104	CcSEcCtD
Topotecan—Dyspepsia—Betamethasone—hematologic cancer	5.5e-06	0.000104	CcSEcCtD
Topotecan—Dyspepsia—Dexamethasone—hematologic cancer	5.5e-06	0.000104	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	5.48e-06	0.000379	CbGpPWpGaD
Topotecan—Urticaria—Triamcinolone—hematologic cancer	5.47e-06	0.000103	CcSEcCtD
Topotecan—Asthenia—Etoposide—hematologic cancer	5.45e-06	0.000103	CcSEcCtD
Topotecan—Body temperature increased—Triamcinolone—hematologic cancer	5.45e-06	0.000103	CcSEcCtD
Topotecan—Anaphylactic shock—Prednisone—hematologic cancer	5.44e-06	0.000103	CcSEcCtD
Topotecan—Angiopathy—Epirubicin—hematologic cancer	5.44e-06	0.000103	CcSEcCtD
Topotecan—Decreased appetite—Betamethasone—hematologic cancer	5.43e-06	0.000103	CcSEcCtD
Topotecan—Decreased appetite—Dexamethasone—hematologic cancer	5.43e-06	0.000103	CcSEcCtD
Topotecan—Nausea—Irinotecan—hematologic cancer	5.42e-06	0.000103	CcSEcCtD
Topotecan—Nausea—Mitoxantrone—hematologic cancer	5.42e-06	0.000103	CcSEcCtD
Topotecan—Immune system disorder—Epirubicin—hematologic cancer	5.41e-06	0.000102	CcSEcCtD
Topotecan—Infection—Prednisone—hematologic cancer	5.41e-06	0.000102	CcSEcCtD
Topotecan—Mediastinal disorder—Epirubicin—hematologic cancer	5.4e-06	0.000102	CcSEcCtD
Topotecan—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.4e-06	0.000102	CcSEcCtD
Topotecan—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.4e-06	0.000102	CcSEcCtD
Topotecan—ABCG2—Metabolism—SLC35B2—hematologic cancer	5.4e-06	0.000373	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GBA—hematologic cancer	5.4e-06	0.000373	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.39e-06	0.000373	CbGpPWpGaD
Topotecan—Back pain—Methotrexate—hematologic cancer	5.39e-06	0.000102	CcSEcCtD
Topotecan—Fatigue—Betamethasone—hematologic cancer	5.39e-06	0.000102	CcSEcCtD
Topotecan—Fatigue—Dexamethasone—hematologic cancer	5.39e-06	0.000102	CcSEcCtD
Topotecan—Chills—Epirubicin—hematologic cancer	5.38e-06	0.000102	CcSEcCtD
Topotecan—Pruritus—Etoposide—hematologic cancer	5.37e-06	0.000102	CcSEcCtD
Topotecan—Pain—Betamethasone—hematologic cancer	5.35e-06	0.000101	CcSEcCtD
Topotecan—Pain—Dexamethasone—hematologic cancer	5.35e-06	0.000101	CcSEcCtD
Topotecan—Nervous system disorder—Prednisone—hematologic cancer	5.34e-06	0.000101	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	5.31e-06	0.000367	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	5.31e-06	0.000367	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL1B—hematologic cancer	5.31e-06	0.000367	CbGpPWpGaD
Topotecan—Alopecia—Epirubicin—hematologic cancer	5.3e-06	0.0001	CcSEcCtD
Topotecan—ABCB1—Allograft Rejection—CASP3—hematologic cancer	5.29e-06	0.000366	CbGpPWpGaD
Topotecan—Skin disorder—Prednisone—hematologic cancer	5.29e-06	0.0001	CcSEcCtD
Topotecan—ABCB1—Allograft Rejection—IL2—hematologic cancer	5.29e-06	0.000366	CbGpPWpGaD
Topotecan—Nausea—Gemcitabine—hematologic cancer	5.28e-06	9.99e-05	CcSEcCtD
Topotecan—Vomiting—Cisplatin—hematologic cancer	5.27e-06	9.97e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	5.26e-06	0.000364	CbGpPWpGaD
Topotecan—Hyperhidrosis—Prednisone—hematologic cancer	5.26e-06	9.95e-05	CcSEcCtD
Topotecan—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	5.25e-06	0.000363	CbGpPWpGaD
Topotecan—Rash—Cisplatin—hematologic cancer	5.23e-06	9.88e-05	CcSEcCtD
Topotecan—Dermatitis—Cisplatin—hematologic cancer	5.22e-06	9.88e-05	CcSEcCtD
Topotecan—Malnutrition—Epirubicin—hematologic cancer	5.22e-06	9.86e-05	CcSEcCtD
Topotecan—Diarrhoea—Etoposide—hematologic cancer	5.2e-06	9.83e-05	CcSEcCtD
Topotecan—Anorexia—Prednisone—hematologic cancer	5.19e-06	9.81e-05	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	5.19e-06	0.000359	CbGpPWpGaD
Topotecan—Ill-defined disorder—Methotrexate—hematologic cancer	5.17e-06	9.78e-05	CcSEcCtD
Topotecan—Anaemia—Methotrexate—hematologic cancer	5.15e-06	9.74e-05	CcSEcCtD
Topotecan—Feeling abnormal—Betamethasone—hematologic cancer	5.15e-06	9.74e-05	CcSEcCtD
Topotecan—Feeling abnormal—Dexamethasone—hematologic cancer	5.15e-06	9.74e-05	CcSEcCtD
Topotecan—Gastrointestinal pain—Betamethasone—hematologic cancer	5.11e-06	9.67e-05	CcSEcCtD
Topotecan—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.11e-06	9.67e-05	CcSEcCtD
Topotecan—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	5.08e-06	0.000351	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	5.08e-06	0.000351	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	5.08e-06	0.000351	CbGpPWpGaD
Topotecan—Hypersensitivity—Triamcinolone—hematologic cancer	5.08e-06	9.6e-05	CcSEcCtD
Topotecan—Back pain—Epirubicin—hematologic cancer	5.05e-06	9.54e-05	CcSEcCtD
Topotecan—Angiopathy—Doxorubicin—hematologic cancer	5.03e-06	9.51e-05	CcSEcCtD
Topotecan—Malaise—Methotrexate—hematologic cancer	5.03e-06	9.51e-05	CcSEcCtD
Topotecan—Dizziness—Etoposide—hematologic cancer	5.02e-06	9.5e-05	CcSEcCtD
Topotecan—Muscle spasms—Epirubicin—hematologic cancer	5.02e-06	9.48e-05	CcSEcCtD
Topotecan—Immune system disorder—Doxorubicin—hematologic cancer	5.01e-06	9.47e-05	CcSEcCtD
Topotecan—Mediastinal disorder—Doxorubicin—hematologic cancer	5e-06	9.45e-05	CcSEcCtD
Topotecan—Leukopenia—Methotrexate—hematologic cancer	4.99e-06	9.43e-05	CcSEcCtD
Topotecan—Chills—Doxorubicin—hematologic cancer	4.98e-06	9.41e-05	CcSEcCtD
Topotecan—Urticaria—Betamethasone—hematologic cancer	4.97e-06	9.39e-05	CcSEcCtD
Topotecan—Urticaria—Dexamethasone—hematologic cancer	4.97e-06	9.39e-05	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.96e-06	9.38e-05	CcSEcCtD
Topotecan—Dizziness—Prednisolone—hematologic cancer	4.95e-06	9.37e-05	CcSEcCtD
Topotecan—Asthenia—Triamcinolone—hematologic cancer	4.94e-06	9.35e-05	CcSEcCtD
Topotecan—Body temperature increased—Dexamethasone—hematologic cancer	4.94e-06	9.34e-05	CcSEcCtD
Topotecan—Body temperature increased—Betamethasone—hematologic cancer	4.94e-06	9.34e-05	CcSEcCtD
Topotecan—Abdominal pain—Betamethasone—hematologic cancer	4.94e-06	9.34e-05	CcSEcCtD
Topotecan—Abdominal pain—Dexamethasone—hematologic cancer	4.94e-06	9.34e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	4.94e-06	0.000342	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTAP—hematologic cancer	4.94e-06	0.000341	CbGpPWpGaD
Topotecan—Nausea—Cisplatin—hematologic cancer	4.92e-06	9.31e-05	CcSEcCtD
Topotecan—Alopecia—Doxorubicin—hematologic cancer	4.9e-06	9.26e-05	CcSEcCtD
Topotecan—Paraesthesia—Prednisone—hematologic cancer	4.89e-06	9.24e-05	CcSEcCtD
Topotecan—Pruritus—Triamcinolone—hematologic cancer	4.87e-06	9.22e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	4.87e-06	0.000337	CbGpPWpGaD
Topotecan—Cough—Methotrexate—hematologic cancer	4.86e-06	9.2e-05	CcSEcCtD
Topotecan—Ill-defined disorder—Epirubicin—hematologic cancer	4.84e-06	9.15e-05	CcSEcCtD
Topotecan—Vomiting—Etoposide—hematologic cancer	4.83e-06	9.13e-05	CcSEcCtD
Topotecan—Malnutrition—Doxorubicin—hematologic cancer	4.83e-06	9.13e-05	CcSEcCtD
Topotecan—Anaemia—Epirubicin—hematologic cancer	4.82e-06	9.12e-05	CcSEcCtD
Topotecan—Dyspepsia—Prednisone—hematologic cancer	4.79e-06	9.06e-05	CcSEcCtD
Topotecan—Rash—Etoposide—hematologic cancer	4.79e-06	9.06e-05	CcSEcCtD
Topotecan—Dermatitis—Etoposide—hematologic cancer	4.78e-06	9.05e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	4.78e-06	0.000331	CbGpPWpGaD
Topotecan—Headache—Etoposide—hematologic cancer	4.76e-06	9e-05	CcSEcCtD
Topotecan—Arthralgia—Methotrexate—hematologic cancer	4.75e-06	8.97e-05	CcSEcCtD
Topotecan—Myalgia—Methotrexate—hematologic cancer	4.75e-06	8.97e-05	CcSEcCtD
Topotecan—Chest pain—Methotrexate—hematologic cancer	4.75e-06	8.97e-05	CcSEcCtD
Topotecan—Decreased appetite—Prednisone—hematologic cancer	4.73e-06	8.95e-05	CcSEcCtD
Topotecan—Rash—Prednisolone—hematologic cancer	4.72e-06	8.93e-05	CcSEcCtD
Topotecan—Dermatitis—Prednisolone—hematologic cancer	4.72e-06	8.92e-05	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.71e-06	8.91e-05	CcSEcCtD
Topotecan—Malaise—Epirubicin—hematologic cancer	4.7e-06	8.9e-05	CcSEcCtD
Topotecan—Fatigue—Prednisone—hematologic cancer	4.69e-06	8.87e-05	CcSEcCtD
Topotecan—Headache—Prednisolone—hematologic cancer	4.69e-06	8.87e-05	CcSEcCtD
Topotecan—Discomfort—Methotrexate—hematologic cancer	4.69e-06	8.87e-05	CcSEcCtD
Topotecan—Leukopenia—Epirubicin—hematologic cancer	4.67e-06	8.83e-05	CcSEcCtD
Topotecan—Back pain—Doxorubicin—hematologic cancer	4.67e-06	8.83e-05	CcSEcCtD
Topotecan—Constipation—Prednisone—hematologic cancer	4.66e-06	8.8e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	4.64e-06	0.000321	CbGpPWpGaD
Topotecan—Muscle spasms—Doxorubicin—hematologic cancer	4.64e-06	8.77e-05	CcSEcCtD
Topotecan—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	4.57e-06	0.000316	CbGpPWpGaD
Topotecan—Dizziness—Triamcinolone—hematologic cancer	4.56e-06	8.61e-05	CcSEcCtD
Topotecan—Cough—Epirubicin—hematologic cancer	4.55e-06	8.61e-05	CcSEcCtD
Topotecan—Anaphylactic shock—Methotrexate—hematologic cancer	4.55e-06	8.6e-05	CcSEcCtD
Topotecan—ABCB1—Metabolism—FTCD—hematologic cancer	4.53e-06	0.000313	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PHYH—hematologic cancer	4.53e-06	0.000313	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GMPS—hematologic cancer	4.53e-06	0.000313	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.53e-06	0.000313	CbGpPWpGaD
Topotecan—Infection—Methotrexate—hematologic cancer	4.52e-06	8.55e-05	CcSEcCtD
Topotecan—Nausea—Etoposide—hematologic cancer	4.51e-06	8.53e-05	CcSEcCtD
Topotecan—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	4.49e-06	0.000311	CbGpPWpGaD
Topotecan—Feeling abnormal—Prednisone—hematologic cancer	4.49e-06	8.48e-05	CcSEcCtD
Topotecan—Asthenia—Dexamethasone—hematologic cancer	4.48e-06	8.48e-05	CcSEcCtD
Topotecan—Asthenia—Betamethasone—hematologic cancer	4.48e-06	8.48e-05	CcSEcCtD
Topotecan—Ill-defined disorder—Doxorubicin—hematologic cancer	4.48e-06	8.47e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	4.48e-06	0.00031	CbGpPWpGaD
Topotecan—Nervous system disorder—Methotrexate—hematologic cancer	4.46e-06	8.44e-05	CcSEcCtD
Topotecan—Anaemia—Doxorubicin—hematologic cancer	4.46e-06	8.44e-05	CcSEcCtD
Topotecan—Thrombocytopenia—Methotrexate—hematologic cancer	4.45e-06	8.42e-05	CcSEcCtD
Topotecan—Gastrointestinal pain—Prednisone—hematologic cancer	4.45e-06	8.42e-05	CcSEcCtD
Topotecan—Nausea—Prednisolone—hematologic cancer	4.45e-06	8.41e-05	CcSEcCtD
Topotecan—Myalgia—Epirubicin—hematologic cancer	4.44e-06	8.4e-05	CcSEcCtD
Topotecan—Chest pain—Epirubicin—hematologic cancer	4.44e-06	8.4e-05	CcSEcCtD
Topotecan—Arthralgia—Epirubicin—hematologic cancer	4.44e-06	8.4e-05	CcSEcCtD
Topotecan—Pruritus—Betamethasone—hematologic cancer	4.42e-06	8.36e-05	CcSEcCtD
Topotecan—Pruritus—Dexamethasone—hematologic cancer	4.42e-06	8.36e-05	CcSEcCtD
Topotecan—Skin disorder—Methotrexate—hematologic cancer	4.42e-06	8.36e-05	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.41e-06	8.34e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—FHL2—hematologic cancer	4.4e-06	0.000304	CbGpPWpGaD
Topotecan—Hyperhidrosis—Methotrexate—hematologic cancer	4.4e-06	8.32e-05	CcSEcCtD
Topotecan—Discomfort—Epirubicin—hematologic cancer	4.39e-06	8.3e-05	CcSEcCtD
Topotecan—Vomiting—Triamcinolone—hematologic cancer	4.38e-06	8.28e-05	CcSEcCtD
Topotecan—Malaise—Doxorubicin—hematologic cancer	4.35e-06	8.23e-05	CcSEcCtD
Topotecan—Rash—Triamcinolone—hematologic cancer	4.34e-06	8.21e-05	CcSEcCtD
Topotecan—Dermatitis—Triamcinolone—hematologic cancer	4.34e-06	8.21e-05	CcSEcCtD
Topotecan—Anorexia—Methotrexate—hematologic cancer	4.34e-06	8.2e-05	CcSEcCtD
Topotecan—Urticaria—Prednisone—hematologic cancer	4.32e-06	8.18e-05	CcSEcCtD
Topotecan—Leukopenia—Doxorubicin—hematologic cancer	4.32e-06	8.17e-05	CcSEcCtD
Topotecan—Headache—Triamcinolone—hematologic cancer	4.32e-06	8.16e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—AGRN—hematologic cancer	4.31e-06	0.000298	CbGpPWpGaD
Topotecan—Abdominal pain—Prednisone—hematologic cancer	4.3e-06	8.14e-05	CcSEcCtD
Topotecan—Body temperature increased—Prednisone—hematologic cancer	4.3e-06	8.14e-05	CcSEcCtD
Topotecan—Diarrhoea—Betamethasone—hematologic cancer	4.28e-06	8.09e-05	CcSEcCtD
Topotecan—Diarrhoea—Dexamethasone—hematologic cancer	4.28e-06	8.09e-05	CcSEcCtD
Topotecan—Anaphylactic shock—Epirubicin—hematologic cancer	4.26e-06	8.05e-05	CcSEcCtD
Topotecan—Infection—Epirubicin—hematologic cancer	4.23e-06	8e-05	CcSEcCtD
Topotecan—Cough—Doxorubicin—hematologic cancer	4.21e-06	7.96e-05	CcSEcCtD
Topotecan—Nervous system disorder—Epirubicin—hematologic cancer	4.18e-06	7.89e-05	CcSEcCtD
Topotecan—Thrombocytopenia—Epirubicin—hematologic cancer	4.17e-06	7.88e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	4.17e-06	0.000288	CbGpPWpGaD
Topotecan—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.14e-06	7.84e-05	CcSEcCtD
Topotecan—ABCB1—Metabolism—SMPD3—hematologic cancer	4.14e-06	0.000287	CbGpPWpGaD
Topotecan—Skin disorder—Epirubicin—hematologic cancer	4.14e-06	7.82e-05	CcSEcCtD
Topotecan—Dizziness—Dexamethasone—hematologic cancer	4.13e-06	7.82e-05	CcSEcCtD
Topotecan—Dizziness—Betamethasone—hematologic cancer	4.13e-06	7.82e-05	CcSEcCtD
Topotecan—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	4.12e-06	0.000285	CbGpPWpGaD
Topotecan—Hyperhidrosis—Epirubicin—hematologic cancer	4.12e-06	7.78e-05	CcSEcCtD
Topotecan—Chest pain—Doxorubicin—hematologic cancer	4.11e-06	7.77e-05	CcSEcCtD
Topotecan—Myalgia—Doxorubicin—hematologic cancer	4.11e-06	7.77e-05	CcSEcCtD
Topotecan—Arthralgia—Doxorubicin—hematologic cancer	4.11e-06	7.77e-05	CcSEcCtD
Topotecan—Nausea—Triamcinolone—hematologic cancer	4.09e-06	7.74e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—IDH2—hematologic cancer	4.09e-06	0.000283	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HMMR—hematologic cancer	4.09e-06	0.000283	CbGpPWpGaD
Topotecan—Paraesthesia—Methotrexate—hematologic cancer	4.09e-06	7.72e-05	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.08e-06	7.72e-05	CcSEcCtD
Topotecan—Discomfort—Doxorubicin—hematologic cancer	4.06e-06	7.68e-05	CcSEcCtD
Topotecan—Anorexia—Epirubicin—hematologic cancer	4.06e-06	7.67e-05	CcSEcCtD
Topotecan—Dyspnoea—Methotrexate—hematologic cancer	4.06e-06	7.67e-05	CcSEcCtD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	4.01e-06	0.000278	CbGpPWpGaD
Topotecan—Hypersensitivity—Prednisone—hematologic cancer	4.01e-06	7.58e-05	CcSEcCtD
Topotecan—Dyspepsia—Methotrexate—hematologic cancer	4e-06	7.57e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	4e-06	0.000277	CbGpPWpGaD
Topotecan—Vomiting—Dexamethasone—hematologic cancer	3.97e-06	7.52e-05	CcSEcCtD
Topotecan—Vomiting—Betamethasone—hematologic cancer	3.97e-06	7.52e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	3.96e-06	0.000274	CbGpPWpGaD
Topotecan—Decreased appetite—Methotrexate—hematologic cancer	3.95e-06	7.48e-05	CcSEcCtD
Topotecan—Rash—Betamethasone—hematologic cancer	3.94e-06	7.45e-05	CcSEcCtD
Topotecan—Rash—Dexamethasone—hematologic cancer	3.94e-06	7.45e-05	CcSEcCtD
Topotecan—Anaphylactic shock—Doxorubicin—hematologic cancer	3.94e-06	7.45e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	3.94e-06	0.000273	CbGpPWpGaD
Topotecan—Dermatitis—Dexamethasone—hematologic cancer	3.94e-06	7.45e-05	CcSEcCtD
Topotecan—Dermatitis—Betamethasone—hematologic cancer	3.94e-06	7.45e-05	CcSEcCtD
Topotecan—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.93e-06	7.43e-05	CcSEcCtD
Topotecan—Fatigue—Methotrexate—hematologic cancer	3.92e-06	7.42e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	3.92e-06	0.000271	CbGpPWpGaD
Topotecan—Headache—Betamethasone—hematologic cancer	3.92e-06	7.4e-05	CcSEcCtD
Topotecan—Headache—Dexamethasone—hematologic cancer	3.92e-06	7.4e-05	CcSEcCtD
Topotecan—Infection—Doxorubicin—hematologic cancer	3.91e-06	7.4e-05	CcSEcCtD
Topotecan—Asthenia—Prednisone—hematologic cancer	3.91e-06	7.39e-05	CcSEcCtD
Topotecan—Pain—Methotrexate—hematologic cancer	3.89e-06	7.36e-05	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.88e-06	7.33e-05	CcSEcCtD
Topotecan—Nervous system disorder—Doxorubicin—hematologic cancer	3.86e-06	7.3e-05	CcSEcCtD
Topotecan—Thrombocytopenia—Doxorubicin—hematologic cancer	3.86e-06	7.29e-05	CcSEcCtD
Topotecan—Pruritus—Prednisone—hematologic cancer	3.85e-06	7.28e-05	CcSEcCtD
Topotecan—ABCB1—Allograft Rejection—TNF—hematologic cancer	3.85e-06	0.000266	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ARNTL—hematologic cancer	3.85e-06	0.000266	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	3.83e-06	0.000265	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	3.83e-06	0.000265	CbGpPWpGaD
Topotecan—Skin disorder—Doxorubicin—hematologic cancer	3.83e-06	7.24e-05	CcSEcCtD
Topotecan—Paraesthesia—Epirubicin—hematologic cancer	3.82e-06	7.23e-05	CcSEcCtD
Topotecan—Hyperhidrosis—Doxorubicin—hematologic cancer	3.81e-06	7.2e-05	CcSEcCtD
Topotecan—Dyspnoea—Epirubicin—hematologic cancer	3.8e-06	7.18e-05	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.78e-06	0.000261	CbGpPWpGaD
Topotecan—Anorexia—Doxorubicin—hematologic cancer	3.76e-06	7.1e-05	CcSEcCtD
Topotecan—Feeling abnormal—Methotrexate—hematologic cancer	3.75e-06	7.09e-05	CcSEcCtD
Topotecan—Dyspepsia—Epirubicin—hematologic cancer	3.75e-06	7.09e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—ACP5—hematologic cancer	3.74e-06	0.000259	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CA9—hematologic cancer	3.74e-06	0.000259	CbGpPWpGaD
Topotecan—Diarrhoea—Prednisone—hematologic cancer	3.72e-06	7.04e-05	CcSEcCtD
Topotecan—Gastrointestinal pain—Methotrexate—hematologic cancer	3.72e-06	7.03e-05	CcSEcCtD
Topotecan—Nausea—Betamethasone—hematologic cancer	3.71e-06	7.02e-05	CcSEcCtD
Topotecan—Nausea—Dexamethasone—hematologic cancer	3.71e-06	7.02e-05	CcSEcCtD
Topotecan—Decreased appetite—Epirubicin—hematologic cancer	3.7e-06	7e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—NCOR2—hematologic cancer	3.69e-06	0.000255	CbGpPWpGaD
Topotecan—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.68e-06	6.95e-05	CcSEcCtD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	3.67e-06	0.000254	CbGpPWpGaD
Topotecan—Fatigue—Epirubicin—hematologic cancer	3.67e-06	6.94e-05	CcSEcCtD
Topotecan—Pain—Epirubicin—hematologic cancer	3.64e-06	6.88e-05	CcSEcCtD
Topotecan—Constipation—Epirubicin—hematologic cancer	3.64e-06	6.88e-05	CcSEcCtD
Topotecan—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	3.64e-06	0.000252	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—B3GAT1—hematologic cancer	3.62e-06	0.00025	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—DCK—hematologic cancer	3.62e-06	0.00025	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ASNS—hematologic cancer	3.62e-06	0.00025	CbGpPWpGaD
Topotecan—Urticaria—Methotrexate—hematologic cancer	3.61e-06	6.83e-05	CcSEcCtD
Topotecan—Dizziness—Prednisone—hematologic cancer	3.6e-06	6.81e-05	CcSEcCtD
Topotecan—Body temperature increased—Methotrexate—hematologic cancer	3.6e-06	6.8e-05	CcSEcCtD
Topotecan—Abdominal pain—Methotrexate—hematologic cancer	3.6e-06	6.8e-05	CcSEcCtD
Topotecan—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	3.59e-06	0.000248	CbGpPWpGaD
Topotecan—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.59e-06	6.79e-05	CcSEcCtD
Topotecan—Paraesthesia—Doxorubicin—hematologic cancer	3.54e-06	6.69e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	3.53e-06	0.000244	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—IDH1—hematologic cancer	3.52e-06	0.000243	CbGpPWpGaD
Topotecan—Dyspnoea—Doxorubicin—hematologic cancer	3.51e-06	6.64e-05	CcSEcCtD
Topotecan—Feeling abnormal—Epirubicin—hematologic cancer	3.51e-06	6.63e-05	CcSEcCtD
Topotecan—Gastrointestinal pain—Epirubicin—hematologic cancer	3.48e-06	6.58e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—TXN—hematologic cancer	3.48e-06	0.000241	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCC3—hematologic cancer	3.48e-06	0.000241	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTO1—hematologic cancer	3.48e-06	0.000241	CbGpPWpGaD
Topotecan—Dyspepsia—Doxorubicin—hematologic cancer	3.47e-06	6.56e-05	CcSEcCtD
Topotecan—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	3.47e-06	0.00024	CbGpPWpGaD
Topotecan—Vomiting—Prednisone—hematologic cancer	3.46e-06	6.54e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	3.45e-06	0.000239	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	3.44e-06	0.000238	CbGpPWpGaD
Topotecan—Rash—Prednisone—hematologic cancer	3.43e-06	6.49e-05	CcSEcCtD
Topotecan—ABCB1—Metabolism—HDC—hematologic cancer	3.43e-06	0.000237	CbGpPWpGaD
Topotecan—Dermatitis—Prednisone—hematologic cancer	3.43e-06	6.48e-05	CcSEcCtD
Topotecan—Decreased appetite—Doxorubicin—hematologic cancer	3.42e-06	6.48e-05	CcSEcCtD
Topotecan—Headache—Prednisone—hematologic cancer	3.41e-06	6.45e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—SPHK1—hematologic cancer	3.4e-06	0.000235	CbGpPWpGaD
Topotecan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.4e-06	6.43e-05	CcSEcCtD
Topotecan—Fatigue—Doxorubicin—hematologic cancer	3.4e-06	6.42e-05	CcSEcCtD
Topotecan—Urticaria—Epirubicin—hematologic cancer	3.38e-06	6.4e-05	CcSEcCtD
Topotecan—Constipation—Doxorubicin—hematologic cancer	3.37e-06	6.37e-05	CcSEcCtD
Topotecan—Pain—Doxorubicin—hematologic cancer	3.37e-06	6.37e-05	CcSEcCtD
Topotecan—Abdominal pain—Epirubicin—hematologic cancer	3.37e-06	6.36e-05	CcSEcCtD
Topotecan—Body temperature increased—Epirubicin—hematologic cancer	3.37e-06	6.36e-05	CcSEcCtD
Topotecan—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	3.36e-06	0.000233	CbGpPWpGaD
Topotecan—Hypersensitivity—Methotrexate—hematologic cancer	3.35e-06	6.34e-05	CcSEcCtD
Topotecan—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	3.35e-06	0.000231	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	3.34e-06	0.000231	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	3.31e-06	0.000229	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	3.3e-06	0.000228	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	3.28e-06	0.000227	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	3.27e-06	0.000226	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—UGT1A1—hematologic cancer	3.27e-06	0.000226	CbGpPWpGaD
Topotecan—Asthenia—Methotrexate—hematologic cancer	3.26e-06	6.17e-05	CcSEcCtD
Topotecan—Feeling abnormal—Doxorubicin—hematologic cancer	3.25e-06	6.14e-05	CcSEcCtD
Topotecan—Nausea—Prednisone—hematologic cancer	3.23e-06	6.11e-05	CcSEcCtD
Topotecan—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.22e-06	6.09e-05	CcSEcCtD
Topotecan—Pruritus—Methotrexate—hematologic cancer	3.22e-06	6.09e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—SLC22A1—hematologic cancer	3.18e-06	0.00022	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CRABP1—hematologic cancer	3.18e-06	0.00022	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CDA—hematologic cancer	3.14e-06	0.000217	CbGpPWpGaD
Topotecan—Hypersensitivity—Epirubicin—hematologic cancer	3.14e-06	5.93e-05	CcSEcCtD
Topotecan—Urticaria—Doxorubicin—hematologic cancer	3.13e-06	5.92e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	3.12e-06	0.000216	CbGpPWpGaD
Topotecan—Body temperature increased—Doxorubicin—hematologic cancer	3.11e-06	5.89e-05	CcSEcCtD
Topotecan—Abdominal pain—Doxorubicin—hematologic cancer	3.11e-06	5.89e-05	CcSEcCtD
Topotecan—Diarrhoea—Methotrexate—hematologic cancer	3.11e-06	5.89e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—ALOX5—hematologic cancer	3.1e-06	0.000214	CbGpPWpGaD
Topotecan—Asthenia—Epirubicin—hematologic cancer	3.05e-06	5.78e-05	CcSEcCtD
Topotecan—ABCB1—Metabolism—PC—hematologic cancer	3.02e-06	0.000209	CbGpPWpGaD
Topotecan—Pruritus—Epirubicin—hematologic cancer	3.01e-06	5.7e-05	CcSEcCtD
Topotecan—Dizziness—Methotrexate—hematologic cancer	3.01e-06	5.69e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—NUP98—hematologic cancer	3e-06	0.000208	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	2.96e-06	0.000205	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	2.92e-06	0.000202	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC35B2—hematologic cancer	2.92e-06	0.000202	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GBA—hematologic cancer	2.92e-06	0.000202	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.92e-06	0.000202	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ADCY7—hematologic cancer	2.91e-06	0.000202	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NCOA3—hematologic cancer	2.91e-06	0.000202	CbGpPWpGaD
Topotecan—Diarrhoea—Epirubicin—hematologic cancer	2.91e-06	5.51e-05	CcSEcCtD
Topotecan—Hypersensitivity—Doxorubicin—hematologic cancer	2.9e-06	5.49e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—NUP214—hematologic cancer	2.89e-06	0.0002	CbGpPWpGaD
Topotecan—Vomiting—Methotrexate—hematologic cancer	2.89e-06	5.47e-05	CcSEcCtD
Topotecan—Rash—Methotrexate—hematologic cancer	2.87e-06	5.42e-05	CcSEcCtD
Topotecan—Dermatitis—Methotrexate—hematologic cancer	2.87e-06	5.42e-05	CcSEcCtD
Topotecan—Headache—Methotrexate—hematologic cancer	2.85e-06	5.39e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—MTR—hematologic cancer	2.83e-06	0.000196	CbGpPWpGaD
Topotecan—Asthenia—Doxorubicin—hematologic cancer	2.83e-06	5.34e-05	CcSEcCtD
Topotecan—Dizziness—Epirubicin—hematologic cancer	2.82e-06	5.32e-05	CcSEcCtD
Topotecan—CYP3A4—Metabolism—FTCD—hematologic cancer	2.79e-06	0.000193	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GMPS—hematologic cancer	2.79e-06	0.000193	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PHYH—hematologic cancer	2.79e-06	0.000193	CbGpPWpGaD
Topotecan—Pruritus—Doxorubicin—hematologic cancer	2.79e-06	5.27e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—ENO2—hematologic cancer	2.78e-06	0.000192	CbGpPWpGaD
Topotecan—Vomiting—Epirubicin—hematologic cancer	2.71e-06	5.12e-05	CcSEcCtD
Topotecan—Nausea—Methotrexate—hematologic cancer	2.7e-06	5.11e-05	CcSEcCtD
Topotecan—ABCG2—Metabolism—GSTT1—hematologic cancer	2.7e-06	0.000187	CbGpPWpGaD
Topotecan—Diarrhoea—Doxorubicin—hematologic cancer	2.7e-06	5.1e-05	CcSEcCtD
Topotecan—Rash—Epirubicin—hematologic cancer	2.68e-06	5.08e-05	CcSEcCtD
Topotecan—Dermatitis—Epirubicin—hematologic cancer	2.68e-06	5.07e-05	CcSEcCtD
Topotecan—ABCB1—Metabolism—MTAP—hematologic cancer	2.67e-06	0.000185	CbGpPWpGaD
Topotecan—Headache—Epirubicin—hematologic cancer	2.67e-06	5.04e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	2.67e-06	0.000184	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SDC1—hematologic cancer	2.64e-06	0.000182	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	2.61e-06	0.000181	CbGpPWpGaD
Topotecan—Dizziness—Doxorubicin—hematologic cancer	2.61e-06	4.93e-05	CcSEcCtD
Topotecan—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.55e-06	0.000177	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	2.54e-06	0.000176	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	2.54e-06	0.000176	CbGpPWpGaD
Topotecan—Nausea—Epirubicin—hematologic cancer	2.53e-06	4.78e-05	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.52e-06	0.000175	CbGpPWpGaD
Topotecan—Vomiting—Doxorubicin—hematologic cancer	2.5e-06	4.74e-05	CcSEcCtD
Topotecan—Rash—Doxorubicin—hematologic cancer	2.48e-06	4.7e-05	CcSEcCtD
Topotecan—Dermatitis—Doxorubicin—hematologic cancer	2.48e-06	4.69e-05	CcSEcCtD
Topotecan—Headache—Doxorubicin—hematologic cancer	2.47e-06	4.67e-05	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	2.46e-06	0.00017	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	2.45e-06	0.00017	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.45e-06	0.000169	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	2.4e-06	0.000166	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FHL2—hematologic cancer	2.38e-06	0.000165	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.36e-06	0.000163	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	2.34e-06	0.000162	CbGpPWpGaD
Topotecan—Nausea—Doxorubicin—hematologic cancer	2.34e-06	4.42e-05	CcSEcCtD
Topotecan—ABCB1—Metabolism—AGRN—hematologic cancer	2.33e-06	0.000161	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	2.28e-06	0.000158	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NQO1—hematologic cancer	2.24e-06	0.000155	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CD44—hematologic cancer	2.24e-06	0.000155	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—B3GAT1—hematologic cancer	2.23e-06	0.000154	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ASNS—hematologic cancer	2.23e-06	0.000154	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—DCK—hematologic cancer	2.23e-06	0.000154	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2.22e-06	0.000153	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—IDH2—hematologic cancer	2.21e-06	0.000153	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMMR—hematologic cancer	2.21e-06	0.000153	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYCS—hematologic cancer	2.12e-06	0.000147	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HDC—hematologic cancer	2.11e-06	0.000146	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HSP90AA1—hematologic cancer	2.11e-06	0.000146	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.1e-06	0.000145	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ARNTL—hematologic cancer	2.08e-06	0.000144	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.04e-06	0.000141	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.04e-06	0.000141	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ACP5—hematologic cancer	2.02e-06	0.00014	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CA9—hematologic cancer	2.02e-06	0.00014	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOR2—hematologic cancer	2e-06	0.000138	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CDA—hematologic cancer	1.93e-06	0.000134	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—IDH1—hematologic cancer	1.9e-06	0.000132	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.9e-06	0.000131	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.89e-06	0.00013	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCC3—hematologic cancer	1.88e-06	0.00013	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTO1—hematologic cancer	1.88e-06	0.00013	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TXN—hematologic cancer	1.88e-06	0.00013	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTP1—hematologic cancer	1.87e-06	0.000129	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PC—hematologic cancer	1.86e-06	0.000129	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SPHK1—hematologic cancer	1.84e-06	0.000127	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.8e-06	0.000124	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GBA—hematologic cancer	1.8e-06	0.000124	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCB1—hematologic cancer	1.77e-06	0.000122	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—UGT1A1—hematologic cancer	1.77e-06	0.000122	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.73e-06	0.00012	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CRABP1—hematologic cancer	1.72e-06	0.000119	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC22A1—hematologic cancer	1.72e-06	0.000119	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NCOR1—hematologic cancer	1.72e-06	0.000119	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTM1—hematologic cancer	1.72e-06	0.000119	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALOX5—hematologic cancer	1.68e-06	0.000116	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.68e-06	0.000116	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTAP—hematologic cancer	1.64e-06	0.000114	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NUP98—hematologic cancer	1.62e-06	0.000112	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ADCY7—hematologic cancer	1.58e-06	0.000109	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOA3—hematologic cancer	1.58e-06	0.000109	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NUP214—hematologic cancer	1.56e-06	0.000108	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTR—hematologic cancer	1.53e-06	0.000106	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCG2—hematologic cancer	1.53e-06	0.000106	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTHFR—hematologic cancer	1.52e-06	0.000105	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ENO2—hematologic cancer	1.5e-06	0.000104	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FHL2—hematologic cancer	1.47e-06	0.000101	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTT1—hematologic cancer	1.46e-06	0.000101	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AGRN—hematologic cancer	1.44e-06	9.94e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SDC1—hematologic cancer	1.42e-06	9.86e-05	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.41e-06	9.79e-05	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.36e-06	9.44e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—IDH2—hematologic cancer	1.36e-06	9.43e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMMR—hematologic cancer	1.36e-06	9.43e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.28e-06	8.86e-05	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.28e-06	8.84e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CG—hematologic cancer	1.28e-06	8.82e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ACP5—hematologic cancer	1.25e-06	8.62e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CA9—hematologic cancer	1.25e-06	8.62e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.23e-06	8.51e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NQO1—hematologic cancer	1.21e-06	8.38e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CD44—hematologic cancer	1.21e-06	8.38e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CREBBP—hematologic cancer	1.18e-06	8.18e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—IDH1—hematologic cancer	1.17e-06	8.1e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.16e-06	8.01e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TXN—hematologic cancer	1.16e-06	8.01e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.16e-06	8.01e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYCS—hematologic cancer	1.15e-06	7.93e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HSP90AA1—hematologic cancer	1.14e-06	7.88e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.13e-06	7.84e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CD—hematologic cancer	1.12e-06	7.76e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALB—hematologic cancer	1.11e-06	7.66e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.09e-06	7.53e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.06e-06	7.33e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.06e-06	7.33e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3R1—hematologic cancer	1.06e-06	7.32e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.03e-06	7.14e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTP1—hematologic cancer	1.01e-06	6.99e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NUP98—hematologic cancer	1e-06	6.92e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CB—hematologic cancer	9.77e-07	6.76e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOA3—hematologic cancer	9.71e-07	6.72e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ADCY7—hematologic cancer	9.71e-07	6.72e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NUP214—hematologic cancer	9.64e-07	6.67e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCG2—hematologic cancer	9.44e-07	6.53e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTR—hematologic cancer	9.44e-07	6.53e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOR1—hematologic cancer	9.29e-07	6.42e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTM1—hematologic cancer	9.29e-07	6.42e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ENO2—hematologic cancer	9.26e-07	6.41e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTT1—hematologic cancer	8.98e-07	6.21e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SDC1—hematologic cancer	8.78e-07	6.07e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTEN—hematologic cancer	8.44e-07	5.84e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTHFR—hematologic cancer	8.21e-07	5.68e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—EP300—hematologic cancer	8.05e-07	5.57e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NQO1—hematologic cancer	7.46e-07	5.16e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CD44—hematologic cancer	7.46e-07	5.16e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYCS—hematologic cancer	7.06e-07	4.89e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	7.02e-07	4.86e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CG—hematologic cancer	6.89e-07	4.77e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CREBBP—hematologic cancer	6.39e-07	4.42e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTP1—hematologic cancer	6.23e-07	4.31e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CD—hematologic cancer	6.06e-07	4.19e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALB—hematologic cancer	5.98e-07	4.14e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CA—hematologic cancer	5.96e-07	4.12e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCB1—hematologic cancer	5.89e-07	4.08e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3R1—hematologic cancer	5.72e-07	3.96e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM1—hematologic cancer	5.72e-07	3.96e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOR1—hematologic cancer	5.72e-07	3.96e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CB—hematologic cancer	5.28e-07	3.66e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.06e-07	3.5e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—hematologic cancer	4.87e-07	3.37e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTEN—hematologic cancer	4.57e-07	3.16e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—EP300—hematologic cancer	4.35e-07	3.01e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.25e-07	2.94e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.94e-07	2.72e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.73e-07	2.58e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALB—hematologic cancer	3.69e-07	2.55e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.53e-07	2.44e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.25e-07	2.25e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CA—hematologic cancer	3.22e-07	2.23e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTEN—hematologic cancer	2.81e-07	1.95e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—EP300—hematologic cancer	2.68e-07	1.86e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—hematologic cancer	2.63e-07	1.82e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.98e-07	1.37e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—hematologic cancer	1.62e-07	1.12e-05	CbGpPWpGaD
